70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
73.20.Z - Market research and public opinion polling
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 753,7 |
EBITDA | 0 | 0 | 753,7 | |
Short time liabilities | 0,7 | 0,5 | -30,7 | |
Income tax | 0 | -94,1 | ||
Equity capital | 0,1 | 0,1 | 0,1 | 3 |
Operating profit (EBIT) | 0 | 0 | 753,7 | |
Assets | 2 | 0,7 | 0,5 | -26,7 |
Net profit (loss) | 0 | 0 | 0 | 754,5 |
Cash | 0,2 | 0,2 | 0 | |
Net income from sale | 0,3 | 2 | 483,7 | |
Liabilities and provisions for liabilities | 2 | 0,7 | 0,5 | -30,7 |
Working assets | 2 | 0,7 | 0,5 | -26,7 |
Depreciation | 0 | 0 | 0 | |
Basic operational activity income | 0,7 | -14,5 | ||
% | % | % | p.p. | |
Profitability of capital | 4,1 | 0,3 | 2,9 | 2,6 |
Equity capital to total assets | 4,3 | 12 | 16,8 | 4,8 |
Gross profit margin | 0,5 | 0,1 | 0,1 | 0 |
EBITDA Margin | 0,1 | 0,1 | 0 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 685 | 81 | -604 | |
Current financial liquidity indicator | 1.1359690427780151 | 1.2021658420562744 | 0,1 | |
Net dept to EBITDA | -722.6961059570312 | -84.6648178100586 | 638 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane